Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 46: 1728-1737, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (56)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schütz, E.
Right arrow Articles by Oellerich, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schütz, E.
Right arrow Articles by Oellerich, M.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 2000;46:1728-1737.)
© 2000 American Association for Clinical Chemistry, Inc.

Articles

Genotyping of Eight Thiopurine Methyltransferase Mutations: Three-Color Multiplexing, "Two-Color/Shared" Anchor, and Fluorescence-quenching Hybridization Probe Assays Based on Thermodynamic Nearest-Neighbor Probe Design

Ekkehard Schütza,1, Nicolas von Ahsen1 and Michael Oellerich1

1 Department of Clinical Chemistry, Georg-August-University, Robert-Koch-Strasse 40, 37075 Göttingen, Germany.
a Author for correspondence. Fax 49-551-39-8551; e-mail eschuetz{at}med.uni-goettingen.de

Background: The inherited deficiency of thiopurine methyltransferase (TPMT) leads to severe myelosuppression in homozygous patients treated with thiopurine derivatives. One in 300 Caucasians has a homozygous TPMT deficiency with no measurable enzyme activity. To date, eight single-point mutations have been characterized; one group (TPMT*3) accounts for 75% of these.

Methods: We used four LightCyclerTM capillaries to investigate all eight mutations. The three mutations on exon 10 were detected in one capillary with a single "shared" anchor labeled 5' with Cy5.5 and 3' with fluorescein. A wild-type-compatible 3'-fluorescein-labeled probe 5' adjacent to the anchor covered the TPMT*7 mutation, and a 5'-LC-RED640-labeled probe 3' adjacent to the anchor covered the TPMT*3C mutation. For TPMT*4, the forward amplification primer was internally labeled with a fluorescence quencher [6-carboxytetramethylrhodamine (TAMRA)], and a 3'-fluorescein-labeled antisense wild-type-compatible probe was placed at the mutation. For TPMT*2 and TPMT*3D, located on exon 5, a shared anchor approach was chosen. TPMT*3B and TPMT*6 were detected in multiplex technique and TPMT*5 in conventional manner. Anchors and probes were designed using a thermodynamic nearest-neighbor model.

Results: All mutations were detected using four capillaries with one amplification protocol in 40 min. The concentrations of the shared anchors had to be decreased to reduce their intrinsic fluorescence resonance energy transfer signals. The quenching approach using TAMRA produced a very reproducible upside-down-shaped melting curve in channel 1 of the LightCycler. Deviations from wild type were easily detected because the smallest melting point shift for any possible mutation under the core of the probes was 1.5 °C.

Conclusions: This total TPMT genotyping approach shows that it is possible to use double site-labeled anchor oligonucleotides, that channel 1 of the LightCycler can be used as detection channel for mutations using a quenching design, and that the designed probes enable detection of wild types with 100% likelihood.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
N. von Ahsen and M. Oellerich
Chip-Based Genotyping: Translation of Pharmacogenetic Research to Clinical Practice
Clin. Chem., July 1, 2007; 53(7): 1186 - 1187.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Reinshagen, E. Schutz, V. W. Armstrong, C. Behrens, C. von Tirpitz, A. Stallmach, H. Herfarth, J. Stein, P. Bias, G. Adler, et al.
6-Thioguanine Nucleotide-Adapted Azathioprine Therapy Does Not Lead to Higher Remission Rates Than Standard Therapy in Chronic Active Crohn Disease: Results from a Randomized, Controlled, Open Trial
Clin. Chem., July 1, 2007; 53(7): 1306 - 1314.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. Schutz, M. Scharfenstein, and B. Brenig
Genotyping of Ovine Prion Protein Gene (PRNP) Variants by PCR with Melting Curve Analysis,
Clin. Chem., July 1, 2006; 52(7): 1426 - 1429.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
M. J. Moser, D. R. Christensen, D. Norwood, and J. R. Prudent
Multiplexed Detection of Anthrax-Related Toxin Genes
J. Mol. Diagn., February 1, 2006; 8(1): 89 - 96.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
E M Frohman, E Havrdova, B Levinson, and O Slanar
Azathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms
Multiple Sclerosis, February 1, 2006; 12(1): 108 - 111.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
N. von Ahsen, V. W. Armstrong, C. Behrens, C. von Tirpitz, A. Stallmach, H. Herfarth, J. Stein, P. Bias, G. Adler, M. Shipkova, et al.
Association of Inosine Triphosphatase 94C>A and Thiopurine S-Methyltransferase Deficiency with Adverse Events and Study Drop-Outs under Azathioprine Therapy in a Prospective Crohn Disease Study
Clin. Chem., December 1, 2005; 51(12): 2282 - 2288.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Graham, M. Liew, C. Meadows, E. Lyon, and C. T. Wittwer
Distinguishing Different DNA Heterozygotes by High-Resolution Melting
Clin. Chem., July 1, 2005; 51(7): 1295 - 1298.
[Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. Takatsu, T. Yokomaku, S. Kurata, and T. Kanagawa
A FRET-based analysis of SNPs without fluorescent probes
Nucleic Acids Res., November 8, 2004; 32(19): e156 - e156.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. von Ahsen, V. W. Armstrong, and M. Oellerich
Rapid, Long-Range Molecular Haplotyping of Thiopurine S-Methyltransferase (TPMT*) *3A, *3B, and *3C
Clin. Chem., September 1, 2004; 50(9): 1528 - 1534.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. Takatsu, T. Yokomaku, S. Kurata, and T. Kanagawa
A new approach to SNP genotyping with fluorescently labeled mononucleotides
Nucleic Acids Res., April 15, 2004; 32(7): e60 - e60.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Haglund, M. Lindqvist, S. Almer, C. Peterson, and J. Taipalensuu
Pyrosequencing of TPMT Alleles in a General Swedish Population and in Patients with Inflammatory Bowel Disease
Clin. Chem., February 1, 2004; 50(2): 288 - 295.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Vrettou, J. Traeger-Synodinos, M. Tzetis, G. Malamis, and E. Kanavakis
Rapid Screening of Multiple {beta}-Globin Gene Mutations by Real-Time PCR on the LightCycler: Application to Carrier Screening and Prenatal Diagnosis of Thalassemia Syndromes
Clin. Chem., May 1, 2003; 49(5): 769 - 776.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
I. M. Mackay, K. E. Arden, and A. Nitsche
Real-time PCR in virology
Nucleic Acids Res., March 15, 2002; 30(6): 1292 - 1305.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Burggraf, S. Kosel, S. Lohmann, R. Beck, and B. Olgemoller
Unexplained DNA Melting Behavior in a Genotyping Assay
Clin. Chem., January 1, 2002; 48(1): 199 - 201.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. von Ahsen, C. T. Wittwer, and E. Schutz
Oligonucleotide Melting Temperatures under PCR Conditions: Nearest-Neighbor Corrections for Mg2+, Deoxynucleotide Triphosphate, and Dimethyl Sulfoxide Concentrations with Comparison to Alternative Empirical Formulas
Clin. Chem., November 1, 2001; 47(11): 1956 - 1961.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Orth, S. Westphal, J. Dierkes, C. Luley, and K. Schlatterer
Rapid Factor XII (46C{->}T) Genotyping by Fluorescence Resonance Energy Transfer in Patients with Coronary Artery Disease or Thrombophilia
Clin. Chem., June 1, 2001; 47(6): 1117 - 1119.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. Teupser, W. Rupprecht, P. Lohse, and J. Thiery
Fluorescence-based Detection of the CETP TaqIB Polymorphism: False Positives with the TaqMan-based Exonuclease Assay Attributable to a Previously Unknown Gene Variant
Clin. Chem., May 1, 2001; 47(5): 852 - 857.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.